z-logo
Premium
A novel quantitative method for evaluating diffuse in‐stent narrowing at follow‐up angiography
Author(s) -
Ishii Yasuhiro,
van Weert Anton W.M.,
Hekking Ellen,
de Marie Karen,
ter Horst Jeroen,
Oemrawsingh Pranobe V.,
Reiber Johan H.C.
Publication year - 2001
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.1289
Subject(s) - medicine , restenosis , stent , lesion , radiology , coronary angiography , angiography , nuclear medicine , target lesion , correlation , cardiology , percutaneous coronary intervention , surgery , geometry , myocardial infarction , mathematics
A new quantitative parameter, diffuse index (DI), was proposed to evaluate objectively whether in‐stent restenosis is diffuse or focal in nature. A total of 343 patients (346 lesions) with Wiktor‐GX, AVE MS‐II, or JOMED stents were evaluated at follow‐up angiography. According to the QCA‐CMS definition, lesion length is derived from the 100% reference diameter function (RDF). By moving the RDF downward, the lesion length, LL(x), at each percentage x of the RDF can be calculated. We have defined the DI by the ratio of this calculated length LL(x) and the total stent length, SL, in other words, DI = [LL(x)/SL]. The percentage plaque area (% PA) was calculated by dividing the plaque area by the sum of the plaque area and luminal area within the stent. An excellent correlation was found between the DI at 88% RDF and the % PA in all three stents (r > 0.88). The individual correlation curves were nearly identical, independent of the type of stent. Furthermore, based on the overall data, the combination of a DI > 0.8 and % PA > 30% correlated with a high incidence of subsequent major adverse cardiac events (13/25 = 52%). From these data, it can be concluded that the diffuse index is a new objective quantitative parameter to describe whether in‐stent restenosis is of focal or diffuse nature. Cathet Cardiovasc Intervent 2001;54:309–317. © 2001 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom